Cell type-specific roles of Rb in retinal differentiation

Rb 在视网膜分化中的细胞类型特异性作用

基本信息

  • 批准号:
    7384066
  • 负责人:
  • 金额:
    $ 42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-09-30 至 2013-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): During retinal development, the decision to exit the cell cycle must be precisely coordinated with cell fate specification and differentiation to ensure that the correct proportion of each cell type is generated. The Rb family of proteins (Rb, p107 and p130) regulate cell cycle exit, cell fate specification, differentiation and survival during development. In the previous funding period, we focused on the unique and overlapping roles of the Rb family in regulating retinal progenitor cell proliferation during development in mice and humans. These studies moved the field forward and allowed us to develop some of the first knockout mouse models of retinoblastoma. We used these and other preclinical models of retinoblastoma to test new therapies and our research has directly impacted an ongoing clinical trial (RET-5) at St. Jude. In this grant proposal, we will extend our previous studies and focus on the role of the Rb family in neuronal cell fate specification and differentiation. Our preliminary data suggest that Rb regulates these two processes through distinct mechanisms. Specifically, we propose that Rb regulates rod photoreceptor cell fate specification by repressing aE2Fs on the Chx10 and Pax6 promoters and Rb regulates rod photoreceptor differentiation through rE2Fs and histone modification to activate the Nrl, Nr2e3 and Crx promoters. This is the first example of such complex regulation of neurogenesis by a tumor suppressor. In contrast to rod photoreceptors, horizontal neurons in the developing retina do not require the Rb family for cell fate specification, migration or differentiation. However, in the absence of the Rb family, mature horizontal cells re-enter the cell cycle and form metastatic retinoblastoma while maintaining their differentiated state. These data challenge the widely held belief in developmental biology that differentiation and proliferation are incompatible in neurons. More importantly they suggest that cells that rely upon Rb for their normal development such as rod photoreceptors are resistant to tumor formation following Rb family inactivation but cells that do not rely upon the Rb family for their normal development such as horizontal cells are more susceptible to tumorigenesis following Rb family gene inactivation. We will determine here if the role of the Rb family during normal development in different cell types directly influences their susceptibility to become tumorigenic.
描述(申请人提供):在视网膜发育期间,退出细胞周期的决定必须与细胞命运指定和分化精确协调,以确保产生每种细胞类型的正确比例。Rb家族蛋白(Rb、p107和p130)在发育过程中调节细胞周期退出、细胞命运指定、分化和生存。在之前的资助期间,我们重点研究了RB家族在小鼠和人类发育过程中调节视网膜前体细胞增殖的独特和重叠的作用。这些研究推动了这一领域的发展,并使我们能够开发出一些最早的视网膜母细胞瘤基因敲除小鼠模型。我们使用这些和其他视网膜母细胞瘤的临床前模型来测试新的治疗方法,我们的研究直接影响了圣裘德正在进行的临床试验(RET-5)。在这项拨款提案中,我们将扩展我们之前的研究,并专注于RB家族在神经细胞命运指定和分化中的作用。我们的初步数据表明,Rb通过不同的机制调节这两个过程。具体地说,我们认为Rb通过抑制Chx10和Pax6启动子上的aE2F来调节杆状感光细胞的命运,Rb通过rE2Fs和组蛋白修饰来激活Nr1、Nr2e3和CRx启动子来调节杆状感光细胞的分化。这是第一个由肿瘤抑制因子对神经发生进行如此复杂调控的例子。与杆状感光器相反,发育中的视网膜中的水平神经元不需要RB家族来指定细胞命运、迁移或分化。然而,在缺乏RB家族的情况下,成熟的水平细胞重新进入细胞周期,形成转移性视网膜母细胞瘤,同时保持其分化状态。这些数据挑战了发育生物学中普遍持有的信念,即神经元的分化和增殖是不相容的。更重要的是,它们表明依赖Rb正常发育的细胞,如杆状感光细胞,对Rb家族失活后的肿瘤形成具有抵抗力,但不依赖Rb家族正常发育的细胞,如水平细胞,在Rb家族基因失活后更容易发生肿瘤。我们将在这里确定RB家族在不同细胞类型的正常发育过程中的作用是否直接影响它们成为肿瘤的易感性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael A Dyer其他文献

Michael A Dyer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael A Dyer', 18)}}的其他基金

In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas
治疗小儿软组织肉瘤的新型药物组合的体内测试
  • 批准号:
    10653061
  • 财政年份:
    2021
  • 资助金额:
    $ 42万
  • 项目类别:
In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas
治疗小儿软组织肉瘤的新型药物组合的体内测试
  • 批准号:
    10300360
  • 财政年份:
    2021
  • 资助金额:
    $ 42万
  • 项目类别:
In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas
治疗小儿软组织肉瘤的新型药物组合的体内测试
  • 批准号:
    10437921
  • 财政年份:
    2021
  • 资助金额:
    $ 42万
  • 项目类别:
Cell-type– and developmental stage–specific regulation of gene expression in the retina
视网膜中基因表达的细胞类型和发育阶段的特异性调控
  • 批准号:
    10333227
  • 财政年份:
    2020
  • 资助金额:
    $ 42万
  • 项目类别:
Cell-type– and developmental stage–specific regulation of gene expression in the retina
视网膜中基因表达的细胞类型和发育阶段的特异性调控
  • 批准号:
    9886721
  • 财政年份:
    2020
  • 资助金额:
    $ 42万
  • 项目类别:
Novel Therapeutic Approaches for the Treatment of Neuroblastoma
治疗神经母细胞瘤的新方法
  • 批准号:
    10602395
  • 财政年份:
    2020
  • 资助金额:
    $ 42万
  • 项目类别:
Novel Therapeutic Approaches for the Treatment of Neuroblastoma
治疗神经母细胞瘤的新方法
  • 批准号:
    10372856
  • 财政年份:
    2020
  • 资助金额:
    $ 42万
  • 项目类别:
Novel Therapeutic Approaches for the Treatment of Neuroblastoma
治疗神经母细胞瘤的新方法
  • 批准号:
    10737754
  • 财政年份:
    2020
  • 资助金额:
    $ 42万
  • 项目类别:
Modeling Retinoblastoma Initiation Using 3D-Retinal Organoids
使用 3D 视网膜类器官模拟视网膜母细胞瘤的发生
  • 批准号:
    10611878
  • 财政年份:
    2020
  • 资助金额:
    $ 42万
  • 项目类别:
Cell-type– and developmental stage–specific regulation of gene expression in the retina
视网膜中基因表达的细胞类型和发育阶段的特异性调控
  • 批准号:
    10576348
  • 财政年份:
    2020
  • 资助金额:
    $ 42万
  • 项目类别:

相似海外基金

Decision Regarding Aspiration, Belief, and Social Economic Status in Education and Job Market
关于教育和就业市场的愿望、信仰和社会经济地位的决定
  • 批准号:
    2858422
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
    Studentship
Doctoral Dissertation Research in Economics: Belief Formation and Adaptation to Climate Change
经济学博士论文研究:信念的形成与气候变化的适应
  • 批准号:
    2242263
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
    Standard Grant
Paranoia and Bias in Social Belief Updating in Clinical High Risk for Psychosis
精神病临床高危人群的偏执和社会信仰偏见更新
  • 批准号:
    10750091
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
In the Name of God: Examining how religious belief and practice influences violent behaviours within NRMs through the study of politically violent gro
以上帝之名:通过研究政治暴力群体,审视宗教信仰和实践如何影响 NRM 内的暴力行为
  • 批准号:
    2890665
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
    Studentship
Effects of language background and belief on goal-oriented reading: An empirical study
语言背景和信念对目标导向阅读的影响:一项实证研究
  • 批准号:
    23K00683
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modeling the dynamics of belief formation: Towards a computational understanding of the timing and accuracy of probability judgments
对信念形成的动态进行建模:对概率判断的时间和准确性进行计算理解
  • 批准号:
    2350258
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
    Continuing Grant
The Norms of Belief and Assertion Investigated by the Methods of Language Analysis and Experimental Philosophy
语言分析和实验哲学方法研究的信念和断言规范
  • 批准号:
    23K00010
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DDRIG in DRMS: Measuring Persuasion Without Measuring a Prior Belief: A New Application of Planned Missing Data Techniques
DRMS 中的 DDRIG:在不衡量先验信念的情况下衡量说服力:计划丢失数据技术的新应用
  • 批准号:
    2242100
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
    Standard Grant
Bilinear Inference Based on Belief Propagation for Non-Orthogonal Multiple Access with Massive IoT Devices
基于置信传播的海量物联网设备非正交多址双线性推理
  • 批准号:
    23K13335
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Belief in mind-body dualism and mental health: The case of body-image issues among social-media users.
对身心二元论和心理健康的信仰:社交媒体用户中身体形象问题的案例。
  • 批准号:
    2891113
  • 财政年份:
    2023
  • 资助金额:
    $ 42万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了